Sign in

CIK 0001907223 · <br>Emerging growth company

Greenland Mines Ltd

Sign in to watch
Ticker
GRML
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
862727441
Phone
(833) 931-6330
Business address
13576 WALNUT STREET, SUITE A, OMAHA, NE, 68144
Former names
Klotho Neurosciences, Inc., ANEW Medical, Inc., Redwoods Acquisition Corp.

Securities

  • GRML Common Stock Nasdaq
  • GRMLW Warrants Nasdaq
  1. 4 Open-market sale Former Director sold 3,500 shares at $9.35 ($32,727)
  2. 4 Open-market buy Chief Financial Officer bought 14,000 shares at $9.72 ($136,080)
  3. 4 Open-market buy Director bought 240,000 shares at $0.23 ($55,944)
  4. 4 Open-market buy Director bought 140,000 shares at $0.18 ($24,822)
  5. 4 Open-market buy Chief Financial Officer bought 1,400,000 shares at $0.18 ($245,280)
  6. 4 Open-market sale Director sold 175,000 shares at $0.23 ($40,548)
  7. 4 Grant or award Chief Financial Officer acquired 2,500,000 shares (grant or award)
  8. 4 Grant or award Director acquired 350,000 shares (grant or award)
  9. 4 Grant or award Director acquired 350,000 shares (grant or award)
  10. 4 Grant or award Director acquired 350,000 shares (grant or award)
  11. 4 Grant or award Director acquired 350,000 shares (grant or award)
  12. 4 Grant or award Chief Executive Officer acquired 2,500,000 shares (grant or award)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Other acquisition Chief Executive Officer acquired 400,000 shares (other)
  17. 4 Grant or award Chief Financial Officer acquired 200,000 shares (grant or award)
  18. 4 Grant or award Director acquired 70,149 shares (grant or award)
  19. 4 Derivatives Options or other derivatives
  20. 4 Grant or award Chief Executive Officer acquired 537,180 shares (grant or award)

Page 1 of 2 · 33 filings